Graftide S 360mg tablet is an immunosuppressant with an active ingredient called Mycophenolate sodium. It belongs to the inosine monophosphate dehydrogenase (IMPDH) inhibitor category. This medicine is used to prevent organ rejection in individuals who have previously received an organ transplant (such as kidney, heart, or liver transplantation). It is prescribed as part of a combination therapy that includes other immunosuppressive drugs. This drug is contraindicated during pregnancy due to the risk of birth defects and miscarriage. It should not be advised in pregnant women unless there are no relevant alternatives and the potential benefits outweigh the risks. Female patients with reproductive potential are highly advised to use effective contraception while taking this tablet to prevent pregnancy. Live vaccines should not be administered while a person is taking Graftide S 360mg tablet due to reduced vaccine effectiveness and the risk of infection. Individuals taking this drug should not donate blood during treatment and at least six weeks after stopping treatment. It ensures that the medication has been adequately cleared from the body before donating blood. It is generally advised not to take this medicine if you are allergic to the drug or any other ingredients. Inform your doctor if you have liver or heart disease before initiating the treatment. As this drug reduces the body's immune defences, it can increase the chance of skin cancer. Individuals must take precautions to limit their exposure to sunlight and ultraviolet (UV) light. Seek your doctor immediately if you develop any bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, or seizures after taking this medicine. Graftide S 360mg tablet is an immunosuppressive medication. It may affect the infant's developing immune system and should be avoided when breastfeeding.